Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10138282 | Peptide antagonist of LL-37 | C. Cheng Kao, Divyendu Singh | 2018-11-27 |
| 9932404 | Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist | Mark Cunningham, Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger +6 more | 2018-04-03 |
| 9522957 | Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists | Mark Cunningham, Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger +6 more | 2016-12-20 |
| 9481731 | Toll-like receptor 3 antagonists | Mark Cunningham, Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger +7 more | 2016-11-01 |
| 9255153 | Polynucleotides encoding Toll-Like Receptor 3 antagonists | Mark Cunningham, Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger +6 more | 2016-02-09 |
| 9238693 | Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies | Mark Cunningham, Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger +6 more | 2016-01-19 |
| 8540986 | Toll-like receptor 3 antagonists | Mark Cunningham, Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger +6 more | 2013-09-24 |
| 8460659 | Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases | Mark Cunningham, Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger +8 more | 2013-06-11 |
| 8409567 | Toll-like receptor 3 antagonists | Mark Cunningham, Yiqing Feng, Katharine Heeringa, Jinquan Luo, Robert Rauchenberger +6 more | 2013-04-02 |
| 8153583 | Toll like receptor 3 antagonists, methods and uses | Jill Carton, Shizhong Chen, Mark Cunningham, Anuk Das, Karen Duffy +12 more | 2012-04-10 |
| 7718778 | Antibody reactive with human toll like receptor 3 | Karen Duffy, Chong Huang, Roberta Lamb, Mouhamadou L. Mbow, Robert Sarisky | 2010-05-18 |